证券记录 · 已归档季度
KROS
Keros Therapeutics, Inc. · Healthcare · Biotechnology
16被追踪持有人
0Δ持有人
12.05M持有股份
$190.67M报告持仓市值
+0新建仓位
−0清仓
动量输入（同类管理人）： 持有人广度 0.0% · 股份流向 +4.9% · 净新建仓位 0.0% — 公式
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q3 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 68 | -2 | 12.51M | $133.89M | +5 | −7 |
| Q1 2026 | 72 | +4 | 12.53M | $138.59M | +8 | −4 |
| Q4 2025 | 68 | +1 | 14.80M | $301.38M | +1 | — |
| Q3 2025 | 16 | 0 | 12.05M | $190.67M | — | — |
| Q2 2025 | 13 | +1 | 9.42M | $125.76M | +2 | −1 |
| Q1 2025 | 9 | -1 | 3.92M | $39.99M | +1 | −2 |
| Q4 2024 | 10 | 0 | 4.67M | $74.00M | +1 | −1 |
| Q3 2024 | 9 | -1 | 4.72M | $274.14M | +1 | −2 |
| Q2 2024 | 10 | — | 3.52M | $160.87M | — | — |
持有人 · Q3 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (被动) | 2.72M | +3.3% | $43.01M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 2 | The Vanguard Group ✦ (被动) | 2.72M | +3.3% | $43.01M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 3 | The Vanguard Group ✦ (被动) | 2.72M | +3.3% | $43.01M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 4 | The Vanguard Group ✦ (被动) | 2.72M | +3.3% | $43.01M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 5 | BlackRock ✦ (被动) | 2.72M | -0.6% | $42.99M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 6 | BlackRock ✦ (被动) | 2.72M | -0.6% | $42.99M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 7 | BlackRock ✦ (被动) | 2.72M | -0.6% | $42.99M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 8 | BlackRock ✦ (被动) | 2.72M | -0.6% | $42.99M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 9 | BlackRock ✦ (被动) | 2.72M | -0.6% | $42.99M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 10 | BlackRock ✦ (被动) | 2.72M | -0.6% | $42.99M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 11 | BlackRock ✦ (被动) | 2.72M | -0.6% | $42.99M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 12 | BlackRock ✦ (被动) | 2.72M | -0.6% | $42.99M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 13 | BlackRock ✦ (被动) | 2.72M | -0.6% | $42.99M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 14 | D. E. Shaw & Co. ✦ | 1.33M | +2.6% | $21.06M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 15 | Goldman Sachs Group ✦ | 1.33M | — | $20.97M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | Goldman Sachs Group ✦ | 1.33M | — | $20.97M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | Goldman Sachs Group ✦ | 1.33M | — | $20.97M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | State Street Global Advisors ✦ (被动) | 1.30M | -5.9% | $20.61M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 19 | Geode Capital Management ✦ (被动) | 837.36K | +1.0% | $13.25M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 20 | Geode Capital Management ✦ (被动) | 837.36K | +1.0% | $13.25M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 21 | Morgan Stanley ✦ | 395.10K | — | $6.25M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | Morgan Stanley ✦ | 395.10K | — | $6.25M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | Morgan Stanley ✦ | 395.10K | — | $6.25M | 0.0% | n/c | 1 | SEC ↗ |
| 24 | Morgan Stanley ✦ | 395.10K | — | $6.25M | 0.0% | n/c | 1 | SEC ↗ |
| 25 | Morgan Stanley ✦ | 395.10K | — | $6.25M | 0.0% | n/c | 1 | SEC ↗ |
| 26 | Morgan Stanley ✦ | 395.10K | — | $6.25M | 0.0% | n/c | 1 | SEC ↗ |
| 27 | Morgan Stanley ✦ | 395.10K | — | $6.25M | 0.0% | n/c | 1 | SEC ↗ |
| 28 | JPMorgan Chase ✦ | 343.88K | — | $5.44M | 0.0% | n/c | 1 | SEC ↗ |
| 29 | JPMorgan Chase ✦ | 343.88K | — | $5.44M | 0.0% | n/c | 1 | SEC ↗ |
| 30 | JPMorgan Chase ✦ | 343.88K | — | $5.44M | 0.0% | n/c | 1 | SEC ↗ |
| 31 | JPMorgan Chase ✦ | 343.88K | — | $5.44M | 0.0% | n/c | 1 | SEC ↗ |
| 32 | JPMorgan Chase ✦ | 343.88K | — | $5.44M | 0.0% | n/c | 1 | SEC ↗ |
| 33 | JPMorgan Chase ✦ | 343.88K | — | $5.44M | 0.0% | n/c | 1 | SEC ↗ |
| 34 | JPMorgan Chase ✦ | 343.88K | — | $5.44M | 0.0% | n/c | 1 | SEC ↗ |
| 35 | JPMorgan Chase ✦ | 343.88K | — | $5.44M | 0.0% | n/c | 1 | SEC ↗ |
| 36 | Arrowstreet Capital ✦ | 258.75K | +300.7% | $4.09M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 37 | AQR Capital Management ✦ | 204.35K | +189.2% | $3.23M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 38 | AQR Capital Management ✦ | 204.35K | +189.2% | $3.23M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 39 | AQR Capital Management ✦ | 204.35K | +189.2% | $3.23M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 40 | AQR Capital Management ✦ | 204.35K | +189.2% | $3.23M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 41 | AQR Capital Management ✦ | 204.35K | +189.2% | $3.23M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 42 | Citadel Advisors ✦ | 176.14K | +669.2% | $2.79M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 43 | Citadel Advisors ✦ | 176.14K | +669.2% | $2.79M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 44 | Renaissance Technologies ✦ | 154.70K | +5.5% | $2.45M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 45 | Fidelity (FMR) ✦ | 100.53K | -38.8% | $1.59M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 46 | Fidelity (FMR) ✦ | 100.53K | -38.8% | $1.59M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 47 | Two Sigma Investments ✦ | 82.52K | +510.3% | $1.31M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 48 | Millennium Management ✦ | 53.35K | +289.2% | $843,934 | 0.0% | ▲ Add | 6 | SEC ↗ |
| 49 | T. Rowe Price ✦ | 49.98K | +3.2% | $791,000 | 0.0% | ▲ Add | 6 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| 本季度无新增被追踪买入方。 |
已清仓
| 本季度无被追踪的退出仓位。 |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 149 持有人, 18.56M 股份, $201.20M 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
公开市场买入 (P)
Aug 17
BIENAIME JEAN JACQUES
Director · 1.00K 股 @ 10.27 · $10,270
公开市场卖出 (S)
Aug 18
Cho Esther
Officer · 4.49K 股 · $46,151
Aug 18
Newton Charles W.
Director · 551 股 · $5,675
Aug 18
Lerner Lorena Raquel
Officer · 3.57K 股 · $36,715
Aug 18
Tanini Annita
Officer · 1.22K 股 · $12,595
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
Jul 29
SC 13G/A — BlackRock, Inc.
Jul 17
SC 13G — BlackRock Portfolio Management LLC
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q3 2025 ·
方法论 ·
通过API获取此数据